Dr. Jim Flatt discusses his role as co-founder and CEO of Brightseed, which is making proactive health more accessible through the discovery and development natural product solutions for food, healthcare and agriculture industries through Forager, a powerful AI-powered and system biology-informed technology platform.
Read MoreFrank Watanabe, President and CEO of Arcutis Biotherapeutics, shares his career from serving in the U.S. Navy and government to leading established and emerging pharmaceutical companies. He discusses his experiences leading Arcutis through an IPO and the pandemic, management style of setting clear goals but ensuring room for individual creativity and flexibility, and advice on choosing a meaningful career.
Pablo Lapuerta, the Executive Vice President and Chief Medical Officer of Lexicon Pharmaceuticals, focuses heavily on genetics and drug development. He discusses the messaging that the pharmaceutical industry needs to do in order to help the public understand the extensive processes behind bringing new drugs to market, improvements that could be made in the FDA’s drug approval process, and a novel drug that he and Lexicon have developed to treat Type I diabetes.
Read MoreThe team, led by Katherine Sizov and Reginald Lamaute, has created a biosensor that can accurately predict when apples in storage rooms have become ripe.
Read MoreDr. Patrick Anquetil is the Chief Executive Officer of Portal Instruments, a medical device company that has developed a high pressure system to administer injections without needles.
Read MoreThe Birth of The Concussion Industry
Read MoreFounding member of the Broad Institute speaks on the effect of automation on new bio-technological research
Read More
